logo
Plus   Neg
Share
Email
Comment

Genmab: Daratumumab Granted Fast Track Designation By FDA - Quick Facts

Genmab A/S (GNMSF.PK) announced that the US Food and Drug Administration has granted Fast Track designation for daratumumab. This designation covers patients with multiple myeloma who have received at least three prior lines of therapy including a proteasome inhibitor (PI) and an immunomodulatory agent (IMiD) or are double refractory to a PI and an IMiD.

In August 2012, Genmab granted Janssen Biotech, Inc. an exclusive worldwide license to develop and commercialize daratumumab.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Verizon Communications Inc. (VZ) reported an adjusted fourth-quarter earnings per share of $0.86, flat with a year ago. On average, 24 analysts polled by Thomson Reuters expected the company to report profit per share of $0.88 for the quarter. Analysts' estimates typically exclude special items. Fourth-quarter... Consumer goods giant Procter & Gamble Co. on Tuesday reported a 68 percent fall in profit for the second quarter from last year as an increase in sales was more than offset by a tax charge related to the U.S. tax reform in the latest quarter and a divestiture gain in the year-ago period. However, both revenue and core earnings per share for the quarter beat analysts' estimates. Shares of easyJet Plc were gaining around 6 percent in London trading after the low-cost airline reported Tuesday higher revenues, traffic and capacity in its first quarter. Looking ahead, revenue per seat at constant currency is expected to increase by mid to high single digits in the first half. Johan Lundgren, Chief Executive, said, "easyJet delivered a strong start to the financial year...
comments powered by Disqus
Follow RTT